Skip to main
USPH

USPH Stock Forecast & Price Target

USPH Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 25%
Buy 75%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

US Physical Therapy Inc is poised for continued growth, particularly in its industrial injury prevention business, which has demonstrated strong momentum, contributing to an anticipated revenue increase of 17.1% year-over-year in this segment. The company has raised its adjusted EBITDA guidance for FY/25 to a range of $93 million to $97 million, reflecting an 8.6% increase compared to the previous year. Overall, these developments underscore a positive outlook for the firm as it capitalizes on its key revenue sources and operational efficiencies.

Bears say

US Physical Therapy Inc. may face challenges in the coming years as it will encounter its first year in 2026 without pricing pressure from its Medicare business since prior to the COVID pandemic. The company's reliance on multiple payment sources, including managed care programs and Medicare/Medicaid, raises concerns about consistent revenue generation, particularly amidst potential regulatory changes. Lastly, the company generates the majority of its revenue from its Physical therapy operations segment, which could limit growth opportunities in the context of evolving market dynamics and competitive pressures.

USPH has been analyzed by 4 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 75% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of U.S. Physical Therapy and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About U.S. Physical Therapy (USPH) Forecast

Analysts have given USPH a Buy based on their latest research and market trends.

According to 4 analysts, USPH has a Buy consensus rating as of Mar 25, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $104.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $104.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

U.S. Physical Therapy (USPH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.